Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Event, Annual Meeting, Business Update

Transgene Announces Upcoming Investor Meetings


Regulatory News:

TRANSGENE (Paris:TNG) today announces that Management will participate in several investor events in January and February 2023, as set out below.

Transgene will meet institutional investors at the 12th Annual LifeSci Advisors Corporate Access Event and at BIO Partnering at JPM in San Francisco from January 9 to 12, 2023, in conjunction with the J.P. Morgan Healthcare conference.

The Company will also attend:

About Transgene
Transgene (Euronext: TNG) is a biotechnology company focused on designing and developing targeted immunotherapies for the treatment of cancer. Transgene's programs utilize viral vector technology with the goal of indirectly or directly killing cancer cells.
The Company's clinical-stage programs consist of two therapeutic vaccines (TG4001 for the treatment of HPV-positive cancers, and TG4050, the first individualized therapeutic vaccine based on the myvac® platform) as well as two oncolytic viruses (TG6002 for the treatment of solid tumors, and BT-001, the first oncolytic virus based on the Invir.IOtm platform).
With Transgene's myvac® platform, therapeutic vaccination enters the field of precision medicine with a novel immunotherapy that is fully tailored to each individual. The myvac® approach allows the generation of a virus-based immunotherapy that encodes patient-specific mutations identified and selected by Artificial Intelligence capabilities provided by its partner NEC.
With its proprietary platform Invir.IOtm, Transgene is building on its viral vector engineering expertise to design a new generation of multifunctional oncolytic viruses. Transgene has an ongoing Invir.IOtm collaboration with AstraZeneca.
Additional information about Transgene is available at: www.transgene.fr
Follow us on Twitter: @TransgeneSA


These press releases may also interest you

at 10:15
Bayer presents latest data from oncology portfolio at 2024 ASCO Annual Meeting
Bayer will present new data across its oncology portfolio at the upcoming American Society of Clinical Oncology (ASCO) Annual Meeting, taking place in Chicago, from May 31 ? June 4, 2024. The breadth of new data in different tumor types underscores...

at 10:15
XR Accessibility Report ? Shows Only 17% of Global Advertisements Utilize Any Kind of Accessibility Features
XR Extreme Reach, a global technology company that powers the creative economy, today released its 2024 Global Advertising Accessibility Index & Trends. The report reveals new insights into advertising accessibility worldwide, and launches the first...

at 10:10
Parallel Bio Launches Clinical Trial in a Dish to Speed Drug Discovery
Parallel Bio, a biotech company using the immune system to cure disease, today announced the release of its Clinical Trial in a Dish for studying the efficacy and safety of new immunotherapies using human models at the earliest stages of drug...

at 10:10
Global Digital Oilfield Industry Research 2024-2034: A $66.31 Billion Market Featuring Prominent Players - Halliburton, Baker Hughes, Weatherford, and SLB - ResearchAndMarkets.com
The "Global Digital Oilfield Market: Focus on Application, Solution, Process, and Region - Analysis and Forecast, 2024-2034" report has been added to ResearchAndMarkets.com's offering. The market is valued at $36.65 Billion in 2024 and is expected...

at 10:10
Broadridge Declares Quarterly Dividend of $0.80 Per Share
Broadridge Financial Solutions, Inc. announced that its Board of Directors has declared a quarterly cash dividend of $0.80 per share. The dividend is payable July 5, 2024 to stockholders of record at the close of business on June 14, 2024. About...

at 10:10
Voice Assistant Builder PolyAI Closes $50 Million Series C; Backers Include Hedosophia, Nvidia and Khosla Ventures
PolyAI, a leading global provider of enterprise voice assistants, has raised $50 million in a Series C round of funding. The round is backed by new investors Hedosophia, Nvidia's NVentures and Zendesk, with follow-on investments from Khosla Ventures,...

More news about Science and technology...


News published on and distributed by: